|
 |
NolvadexThis page contains recent news articles, when available, and an overview of Nolvadex but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Nolvadex (when available) Tamoxifen belongs to a class of drugs called selective estrogen receptor modulators (SERMs), which have both estrogenic and antiestrogenic effects. Tamoxifen has the same nucleus as diethylstilbestrol but possesses an additional side chain (trans isomer) which accounts for its antiestrogenic activity. Tamoxifen, chemically related to clomiphene., is used to in the therapy of metastatic breast cancer. for the treatment of breast cancer Mechanism Of Action: Tamoxifen binds to estrogen receptors (ER), inducing a conformational change in the receptor. This results in a blockage or change in the expression of estrogen dependent genes. The prolonged binding of tamoxifen to the nuclear chromatin of these results in reduced DNA polymerase activity, impaired thymidine utilization, blockade of estradiol uptake, and decreased estrogen response. It is likely that tamoxifen interacts with other coactivators or corepressors in the tissue and binds with different estrogen receptors, ER-alpha or ER-beta, producing both estrogenic and antiestrogenic effects. News Articles on Tamoxifen Sequential Treatment of Breast Cancer with Femara® and Tamoxifen ... - Aug 27, 2009 Researchers affiliated with the BIG I-98 Collaborative Group have reported that sequential treatment with Femara® (letrozole) and tamoxifen (Nolvadex®) does Cancer Consultants Breastfeeding May Cut Hereditary Breast Cancer Risk - Aug 10, 2009 ...cancer but compared favorably to the impact of hormonal treatments -- like five years of tamoxifen (Nolvadex) -- for high-risk women, Stuebe said. MedPage Today 乳腺病å?ƒä»€ä¹ˆè?¯ - Aug 18, 2009 ...阿斯利康日å‰?表示，由于公å?¸ä»–莫昔芬å“?牌è?¯Nolvadex销售业绩近年æŒ?ç»ä¸‹é™?，其已ç»?å?‘FDAæ??交了将于今年6月底å?œæ¢é”€å”®è¯¥è?¯çš„申请。 æ?®é˜¿æ–¯åˆ©åº·å…¬å¸ƒçš„æ•°æ?®ï¼ŒNolvadex在 医盟网健康资讯 Un combat pendant mais aussi après... - Aug 17, 2009 12 mois d'herceptine (traitement par injection comme pour les chimio) puis 5 ans de traitement oral quotidien (Nolvadex) avec injection tous les 3 mois L'Internaute Magazine Donne in premenopausa con tumore alla mammella in fase iniziale ... - Aug 5, 2009 Zoladex ) e il Tamoxifene ( 20 o 40 mg al giorno; Nolvadex ), somministrati per 2 anni. Le donne sono state assegnate in maniera casuale a ricevere una XagenaSalute liquid nolvadex - 14 Jul 2009 Mr. Gardiner that my investigations and decisions are not true elements of intimacy a cup of his terrible interview with the tip of liquid nolvadex my Glace Bay Gleaner Argument over barking dog leads to death - 14 Jul 2009 Accutane Seattle clomid with triplets Cialis Professional symptoms of zoloft working? cipro and std treatment Nolvadex D prednisone stopped taking side ohmidog! Women Treated for Ductal Carcinoma In Situ (DCIS) Fail to Get ... - Jul 6, 2009 ...being between the ages of 60 and 69 years; use of hormonal therapy; history of radiation therapy or radiation therapy; and use of tamoxifen (Nolvadex®). Cancer Consultants Pay-for-delay deals are illegal, says US Justice Dept - Jul 8, 2009 AstraZeneca and Barr relating to the breast-cancer drug Nolvadex (tamoxifen), has reportedly said it will now reconsider its position in that case. Pharma Times 術後è?·çˆ¾è’™æ²»ç™‚ å?¯æ¸›å°‘乳癌復發å?±éšª - Jun 30, 2009 ...商å“?å??為Nolvadex (或Tadexã€‚æ ¹æ“šä»¥å¾€å°?數å?ƒå??ä¹³ç™Œæ‚£è€…æ‰€é€²è¡Œçš„ç ”ç©¶ï¼Œå¾—çŸ¥ä¹³ç™Œè¡“å¾Œæ‚£è€†æ¯?æ—¥æœ?用Nolvadex，連續æœ?用數年，å?¯æ¸›å°‘乳癌復發的å?±éšªã€‚ uho優活健康網 Many BRCA Carriers Opt for Prophylactic Mastectomy to Ease ... - Apr 14, 2009 ...regarding screening techniques (mammogram and breast self-exam) and prophylactic strategies (tamoxifen [Nolvadex®] and prophylactic mastectomy). Cancer Consultants New ACOG Guidelines Recommend Routine Genetic Risk Assessment - Apr 9, 2009 Chemoprevention: Hormonal therapy with tamoxifen (Nolvadex®) has been shown to reduce the risk of breast cancer among women with a BRCA2 mutation. Cancer Consultants La pioggia obbliga i rovatesi ad uno Sbarazzo a metà . Domenica 26 ... - Apr 19, 2009 ...fda on viagra herbal viagra forums; smooth muscle piperazine viagra? nolvadex viagra patent levitra; viagra anxiety cheap generic viagra taking viagra Rovato.org Cancro al seno: il trattamento con Anastrozolo è associato a ... - Mar 31, 2009 ...ha mostrato che l’Anastrozolo ( Arimidex ) ha una maggiore efficacia e una migliore tollerabilità rispetto al Tamoxifene ( Nolvadex ). XagenaSalute GENETICS: Hereditary breast and ovarian cancers - 18 Mar 2009 Chemoprevention trials with tamoxifen (Nolvadex) have demonstrated decreased breast cancer rates in treatment groups but also higher rates of endometrial Journal of the American Academy of Physician Assistants Carcinoma mammario: il Megestrolo riduce i sintomi vasomotori ... - 18 Mar 2009 M0 dopo il termine dei trattamenti chirurgici e chemioterapici e dopo almeno 4 mesi dal trattamento a base di Tamoxifene ( se prescritto; Nolvadex ). XagenaSalute Poor Compliance with Adjuvant Arimidex® in Women with Breast Cancer - Mar 11, 2009 ...[1] Several randomized studies have shown that tamoxifen (Nolvadex®) and aromatase inhibitors such as Arimidex administered for five or more years Cancer Consultants Daily Cancer News - Mar 10, 2009 These therapies include tamoxifen (Nolvadex®) as well as agents known as aromatase inhibitors. Tamoxifen acts by blocking estrogen receptors, Cancer Consultants Nolvadex buy - Jan 17, 2009 Decisions nolvadex buy is to writing prescription to authority the nolvadex buy CD adipex fillers all nolvadex buy before has saying the money thats if to Griggs County Courier, Meta-analyses of aromatase inhibitors versus tamoxifen - Feb 3, 2009 ...and cohort 2 trials: Austrian Breast and Colorectal Cancer Study Group (ABCSG) 8, Arimidex-Nolvadex (ARNO) 95; Intergroup Exemestane Study (IES)/ BIG American Journal of Hemotology and Oncology, Hormone treatment plus radiotherapy for locally advanced breast cancer - Jan 21, 2009 They include Nolvadex, Soltamox and Tamofen. Reduce the chance of your cancer coming back. In one study, cancer came back in 5 in 10 women treated with both guardian.co.uk, What treatments work for breast pain? - Jan 21, 2009 ...[3] [8] [9] Tamoxifen (brand names Nolvadex, Nolvadex-D, Soltamox) is not licensed for treating breast pain in the UK. This doesn't mean it can't be used guardian.co.uk, Risk Assessment and Individualized Therapy: A Report from the 2008 ... - Jan 29, 2009 ...risk of distant recurrences among postmenopausal, hormone-positive early breast cancer patients who are treated with Arimidex or tamoxifen (Nolvadex®). Cancer Consultants, Reduced Breast Density May Indicate a Response to Tamoxifen - Dec 22, 2008 New research indicates that when the use of tamoxifen (Nolvadex®) results in a reduction of breast density, this change in breast density serves as an Cancer Consultants, Aromatase Inhibitors Improve Outcomes in Early Breast Cancer - Dec 17, 2008 ...results in fewer recurrences than treatment with tamoxifen (Nolvadex®) among postmenopausal women with early, hormone receptor-positive breast cancer. Cancer Consultants, Adjuvant Aromatase Inhibitors Improve Outcomes Compared with ... - Dec 16, 2008 ...of recurrences and mortality compared with tamoxifen (Nolvadex®) in the treatment of hormone-positive, early breast cancer among postmenopausal women. Cancer Consultants, Oncotype DXâ„¢ Predicts Risk of Distant Recurrences Among Women with ... - Dec 19, 2008 ...hormone-positive early breast cancer patients who are treated with either tamoxifen (Nolvadex®) or Arimidex® (anastrozole). These results were recently Cancer Consultants, Oncotype DX® Predicts Recurrence Risk in Node-negative and Node ... - Dec 18, 2008 Among women with early, hormone receptor-positive breast cancer treated with either tamoxifen (Nolvadex®) or Arimidex® (anastrozole), the Oncotype DX test Cancer Consultants, Denosumab Improves Bone Density in Breast Cancer Patients ... - Dec 16, 2008 These therapies include tamoxifen (Nolvadex®) as well as agents known as aromatase inhibitors. Tamoxifen acts by blocking estrogen receptors, Cancer Consultants, Mayo Clinic scientists unravel breast cancer drug mysteries - Dec 23, 2008 The drug is sold through AstraZeneca under the trade names Nolvadex, Istubal and Valodex, but is widely referred to by its generic name. Jacksonville Business Journal, Research and Markets: The Breast Cancer Market Was Estimated To Be ... - Dec 19, 2008 ...drug resistance develops against cytotoxic and hormonal therapies; for example, between 25-35% of patients develop resistance to Nolvadex (tamoxifen). Earthtimes (press release), Family History of Breast Cancer Increases Risk Regardless of BRCA ... - Dec 4, 2008 ...breast cancer and typically undergo more vigilant screening, chemoprevention with tamoxifen (Nolvadex®), and sometimes even prophylactic surgery. Cancer Consultants, Breast Cancer Prevention: High-Risk Women Face Difficult Decisions - Dec 4, 2008 The drug tamoxifen (Nolvadex or Tamone) is a hormone that blocks the effect of estrogen. Five years of treatment with tamoxifen can reduce breast cancer Gather.com, Researchers Uncover Cause Of Tamoxifen Resistance - Nov 13, 2008 Tamoxifen Citrate, sold under the brand name Nolvadex, is commonly used in conjunction with radiation to treat breast cancer. Nolvadex blocks some of the InjuryBoard.com, Poor Compliance with Tamoxifen Leads to Higher Recurrence Rates - Nov 13, 2008 ...receptor-positive localized breast cancer are not compliant with prescribed tamoxifen (Nolvadex®), resulting in a higher rate of recurrent disease. Cancer Consultants, Breast Cancer Patients Suffering Side Effects from Hormone Therapy ... - Nov 6, 2008 Researchers from the United Kingdom recently conducted a study to evaluate outcomes among women treated with either tamoxifen (Nolvadex®) or Arimidex® Cancer Consultants, Cancro al seno: le donne sono ancora a rischio di recidiva dopo 5 ... - Nov 18, 2008 ...per le donne in postmenopausa, che hanno completato i 5 anni della terapia con Tamoxifene ( Nolvadex ), non ne esistono per le donne in premenopausa. XagenaSalute, Denosumab Effective in Treating Bone Loss Induced by Aromatase ... - Oct 17, 2008 Aromatase inhibitors confer a survival benefit when compared to Nolvadex® (tamoxifen) among these patients; however, one of the main concerns associated Cancer Consultants, Groeihormonen uit lijken en vrouwenborsten - Oct 17, 2008 Ik wist toen nog niet dat ik ook Nolvadex moest nemen. De verharding bleef tot ik ze in 2005 operatief liet verwijderen. Het grappige is dat veel van mijn Sportwereld, Geen compensatie voor kankerpatiënten met hormoongevoelige medicatie - Oct 6, 2008 Kanker behoort tot de chronische ziekten en te verwachten was dat de belangrijkste medicatie bij hormoongevoelige tumoren als Nolvadex (Tamoxifen) letrozole Nieuwsbank (abonnement), Ik vrees elke dag voor een hartstilstand (update) - Oct 18, 2008 Ik wist toen nog niet dat ik ook Nolvadex moest nemen. De verharding bleef tot ik ze in 2005 operatief liet verwijderen. Het grappige is dat veel van mijn Hardloop Krant, The side effects of deca - Aug 31, 2008 Higher dosages will come along with new side effects but this additional amount can be prevented from becoming harmful by adding Nolvadex, a drug that will Corsavoo.com, Zometa® Helps Prevent Bone Loss in Early Breast Cancer - Aug 29, 2008 The trial included 404 patients who were treated with one of the following therapies: tamoxifen (Nolvadex®) plus Zoladex® (goserelin) (both of which are Cancer Consultants, Oncotype DX® Accurately Determines HER2 Status in Breast Cancer - Sep 11, 2008 These therapies include tamoxifen [Nolvadex®] as well as agents known as aromatase inhibitors. Tamoxifen acts by blocking estrogen receptors, Cancer Consultants, Daily Cancer News - Sep 10, 2008 These therapies include tamoxifen [Nolvadex®] as well as agents known as aromatase inhibitors. Tamoxifen acts by blocking estrogen receptors, Cancer Consultants, Health, Hope, Heroes: Rita's Story - Jul 11, 2008 My tumor was estrogen fed so I was fortunate that there was a NEW drug called Nolvadex aka Tamoxifen Citrate which had recently been distributed by the KCCI.com, Steroidy: NejdÅ™Ãv z vás udÄ›lajà frajera, pak vás zniÄ?à - Jul 23, 2008 Je jich celá Å™ada a majà mnoho názvů - namátkou tÅ™eba Dianabol, Oxandrolon, Nandrolon a Nolvadex. Majà napomoct růstu svalové hmoty, sÃly a agrese. Super.cz, Donne anziane: prevenzione delle fratture vertebrali con Evista - Jul 22, 2008 Il Raloxifene è efficace quanto il Tamoxifene ( Nolvadex ) nel ridurre il rischio di carcinoma invasivo alla mammella. Il principale problema di sicurezza XagenaSalute, Drugmakers Offer Aid To People 'on the Edge' - Jun 30, 2008 The drugmaker's first PAP, initiated in 1978, provided access to the breast cancer medicine Nolvadex. In the three decades since, the company has sponsored Washington Post, Hormone replacement therapy has its risks - Jun 27, 2008 Lobular breast cancer can be treated with hormone-based therapies, such as tamoxifen (Nolvadex), if caught early. Experts believe the incidence of lobular News 8 Austin, Oncotype DX® Also Provides Information About Breast Cancer Hormone ... - Jun 24, 2008 These therapies include tamoxifen [Nolvadex®] as well as agents known as aromatase inhibitors. Tamoxifen acts by blocking estrogen receptors, Cancer Consultants, Adjuvant Zometa® Improves Outcomes in Hormone-positive Breast ... - 02 Jun 2008 3) Nolvadex® (tamoxifen) plus Zometa; 4) Nolvadex alone. Treatment was continued for three years; the median follow-up of the trial was five years. Cancer Consultants, Addition of RAD001 to Femara® Improves Response to Breast Cancer ... - 02 Jun 2008 These therapies include tamoxifen [Nolvadex®] as well as agents known as aromatase inhibitors. Tamoxifen acts by blocking estrogen receptors, Cancer Consultants, Tamoxifen: 1001 uses of cancer drug extends to bipolar disorder - May 8, 2008 Tamoxifen - The breast cancer drug tamoxifen-marketed in the UK as Emblon, Noltam and Tamofen, and as Nolvadex in the US and the UK-has been enjoying some What Doctors Don't Tell You, Specific Gene Mutations May Affect Response to Tamoxifen in Breast ... - May 6, 2008 Mutations within the CYPD2 gene may affect the way in which a patient with hormone-positive breast cancer responds to tamoxifen (Nolvadex®). Cancer Consultants, From Mr Average ... to superman - May 17, 2008 A week's worth of double Nolvadex doses got the gyno under control. But by then my hair had started falling out. I have a scalp of unruly, bushman-like red The Observer, Deciding on breast cancer treatment: Tamoxifen versus aromatase ... - May 13, 2008 There are two main types of anti-estrogen medications: tamoxifen (Nolvadex), which blocks the ability of estrogen to stimulate cancer cell growth, Gather.com, Femara cuts cancer recurrence even if started late - 11 Mar 2008 But benefits of the pill, sold by AstraZeneca under the brand Nolvadex and also sold generically, fall significantly after five years. Reuters Clinical Oncology Publishes Findings from First-Ever Initiative on ... - 11 Mar 2008 AstraZeneca has provided the financial support for the five-year project and has donated (tamoxifen citrate) NOLVADEX and (anastrozole). ARIMIDEX. CSRwire.com (press release) Early Zometa® Prevents Bone Loss in Postmenopausal Women with ... - Mar 4, 2008 Femara is an aromatase inhibitior that is more effective than tamoxifen (Nolvadex®) in preventing recurrences in postmenopausal women with hormone Cancer Consultants, Ex-plastic surgeon killed wife, self, police say - Feb 15, 2008 ...drugs such as Nolvadex, Proscar, Clomid, Tamoxifen, Vicodin, Androgel, Ritalin and Viagra - "without accepted medical indication and/ or justification. Newsday, Risk Factors Identified for Uterine Sarcoma Survival - Feb 20, 2008 ...race, history of colorectal cancer, and use of the drug tamoxifen (Nolvadex®). This recent study evaluated results of the Surveillance, Epidemiology, Cancer Consultants, Certain Elderly Breast Cancer Patients More Likely to Die from ... - Feb 13, 2008 The hormone agent Femara® (letrozole) was compared to placebo (inactive substitute) following five years of treatment with tamoxifen (Nolvadex®) among Cancer Consultants, Targeted Therapies: A New Generation of Cancer Treatments - Mar 6, 2008 For decades, the use of the hormone receptor modulator tamoxifen (Nolvadex, brand no longer available in the United States) has been limited to the two RedOrbit, Fears of Recurrence Linked to Anxiety After DCIS Diagnosis - Feb 12, 2008 Among them, 34% reported having undergone mastectomy, 50% had received radiation therapy, and 43% took tamoxifen (Nolvadex). Nevertheless, a substantial MedPage Today, Brand Names/Synonyms: Nolvadex is also known by the following brand names and/or synonyms,Citrate; Apo-Tamox; CCRIS 3275; CTX; Citofen; Crisafeno; Diemon; Gen-Tamoxifen; HSDB 6782; Istubol; Kessar; Noltam; Nolvadex; Nolvadex-D; Nourytam; Novo-Tamoxifen; Oncomox; Pms-Tamoxifen; Retaxim; TRANS FORM OF TAMOXIFEN; Tamizam; Tamofen; Tamone; Tamoxasta; Tamoxen; Tamoxifen; Tamoxifen Citrate; Tamoxifen Drug Standard Solution; Tamoxifen and Its Salts; Tamoxifene [Inn-French]; Tamoxifeno [Inn-Spanish]; Tamoxifenum [Inn-Latin]; Trans-Tamoxifen; Valodex; Zemide Drug Category: Nolvadex is categorized under the following by the FDA: Antineoplastic Agents; ATC:L02BA01 Dosage Forms: TABLET Absorption: Not Available Interactions: -->Interactions for Tamoxifen: When NOLVADEX is used in combination with coumarin-type anticoagulants, a significant increase in anticoagulant effect may occur. Where such coadministration exists, careful monitoring of the patientís prothrombin time is recommended. In the NSABP P-1 trial, women who required coumarin-type anticoagulants for any reason were ineligible for participation in the trial. There is an increased risk of thromboembolic events occurring when cytotoxic agents are used in combination with NOLVADEX. Tamoxifen reduced letrozole plasma concentrations by 37%. The effect of tamoxifen on metabolism and excretion of other antineoplastic drugs, such as cyclophosphamide and other drugs that require mixed function oxidases for activation, is not known. Tamoxifen and N-desmethyl tamoxifen plasma concentrations have been shown to be reduced when coadministered with rifampin or aminoglutethimide. Induction of CYP3A4-mediated metabolism is considered to be the mechanism by which these reductions occur; other CYP3A4 inducing agents have not been studied to confirm this effect. One patient receiving NOLVADEX with concomitant phenobarbital exhibited a steady state serum level of tamoxifen lower than that observed for other patients (ie, 26 ng/mL vs. mean value of 122 ng/mL). However, the clinical significance of this finding is not known. Rifampin induced the metabolism of tamoxifen and significantly reduced the plasma concentrations of tamoxifen in 10 patients. Aminoglutethimide reduces tamoxifen and N desmethyl tamoxifen plasma concentrations. Medroxyprogesterone reduces plasma concentrations of N-desmethyl, but not tamoxifen. Concomitant bromocriptine therapy has been shown to elevate serum tamoxifen and N-desmethyl tamoxifen. Drug/Laboratory Testing Interactions: During postmarketing surveillance, T4 elevations were reported for a few postmenopausal patients which may be explained by increases in thyroid-binding globulin. These elevations were not accompanied by clinical hyperthyroidism. Variations in the karyopyknotic index on vaginal smears and various degrees of estrogen effect on Pap smears have been infrequently seen in postmenopausal patients given NOLVADEX. In the postmarketing experience with NOLVADEX, infrequent cases of hyperlipidemias have been reported. Periodic monitoring of plasma triglycerides and cholesterol may be indicated in patients with pre-existing hyperlipidemias . |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |